Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 20628308)

1.

Direct economic burden of chronic hepatitis C virus in a United States managed care population.

Davis KL, Mitra D, Medjedovic J, Beam C, Rustgi V.

J Clin Gastroenterol. 2011 Feb;45(2):e17-24. doi: 10.1097/MCG.0b013e3181e12c09.

PMID:
20628308
2.

Population-based hepatitis C surveillance and treatment in a national managed care organization.

Shatin D, Schech SD, Patel K, McHutchison JG.

Am J Manag Care. 2004 Apr;10(4):250-6.

3.

Burden of illness of hepatitis C from a managed care organization perspective.

Armstrong EP, Charland SL.

Curr Med Res Opin. 2004 May;20(5):671-9.

PMID:
15140332
5.

Costs of hepatitis C.

Leigh JP, Bowlus CL, Leistikow BN, Schenker M.

Arch Intern Med. 2001 Oct 8;161(18):2231-7.

PMID:
11575980
6.

Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users.

Brown K, Crofts N.

Aust N Z J Public Health. 1998;22(3 Suppl):384-8.

PMID:
9629827
7.

Chronic hepatitis C: an age wave of disease burden.

McHutchison JG, Bacon BR.

Am J Manag Care. 2005 Oct;11(10 Suppl):S286-95; quiz S307-11. Review.

8.

The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period.

Jhaveri R, Grant W, Kauf TL, McHutchison J.

J Pediatr. 2006 Mar;148(3):353-8.

PMID:
16615966
10.

The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.

Sterling RK, Brown RS Jr, Hofmann CM, Luketic VA, Stravitz RT, Sanyal AJ, Contos MJ, Mills AS, Smith V, Shiffman ML.

Am J Gastroenterol. 2005 Feb;100(2):313-21.

PMID:
15667488
11.

Epidemiology of hepatitis C in the United States.

Williams I.

Am J Med. 1999 Dec 27;107(6B):2S-9S.

PMID:
10653448
12.

Making it happen: managed care considerations in vanquishing hepatitis C.

McHutchison JG, Bacon BR, Owens GS.

Am J Manag Care. 2007 Dec;13 Suppl 12:S327-36; quiz S337-40. Review.

13.

Economic burden of rhinitis in managed care: a retrospective claims data analysis.

Dalal AA, Stanford R, Henry H, Borah B.

Ann Allergy Asthma Immunol. 2008 Jul;101(1):23-9. doi: 10.1016/S1081-1206(10)60830-7.

PMID:
18681080
14.
15.

The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.

Asche CV, Joish VN, Camacho F, Drake CL.

Curr Med Res Opin. 2010 Aug;26(8):1843-53. doi: 10.1185/03007995.2010.488037.

PMID:
20515321
16.

Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.

Buti M, San Miguel R, Brosa M, Cabasés JM, Medina M, Angel Casado M, Fosbrook L, Esteban R.

J Hepatol. 2005 May;42(5):639-45.

PMID:
15826711
17.

The burden of hepatitis C in the United States.

Kim WR.

Hepatology. 2002 Nov;36(5 Suppl 1):S30-4. Review.

PMID:
12407574
18.

Projecting future complications of chronic hepatitis C in the United States.

Davis GL, Albright JE, Cook SF, Rosenberg DM.

Liver Transpl. 2003 Apr;9(4):331-8.

19.

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.

McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.

J Clin Psychiatry. 2006 Aug;67(8):1187-93.

PMID:
16965195
20.

Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin.

Brixner DI, Ye X, Chu TC, Blumentals WA, Hassanein TI.

Am J Health Syst Pharm. 2009 Dec 15;66(24):2171-8. doi: 10.2146/ajhp080711.

PMID:
19966085
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk